188 related articles for article (PubMed ID: 15044039)
1. Role of dopamine D1 receptors in the striatal and cortical fos expression induced by the muscarinic agonist pilocarpine.
Wirtshafter D
Eur J Pharmacol; 2004 Mar; 488(1-3):85-90. PubMed ID: 15044039
[TBL] [Abstract][Full Text] [Related]
2. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Lee J; Rushlow WJ; Rajakumar N
Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
[TBL] [Abstract][Full Text] [Related]
3. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
4. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression.
Wirtshafter D
Brain Res; 2006 Apr; 1085(1):127-31. PubMed ID: 16564505
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
Steiner H; Gerfen CR
J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats.
Morelli M; Pinna A; Fenu S; Carta A; Cozzolino A; Di Chiara G
Synapse; 1994 Dec; 18(4):288-93. PubMed ID: 7886620
[TBL] [Abstract][Full Text] [Related]
7. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
8. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
Saklayen SS; Mabrouk OS; Pehek EA
J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
[TBL] [Abstract][Full Text] [Related]
9. D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration.
Muller DL; Unterwald EM
J Pharmacol Exp Ther; 2005 Jul; 314(1):148-54. PubMed ID: 15772255
[TBL] [Abstract][Full Text] [Related]
10. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
[TBL] [Abstract][Full Text] [Related]
11. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
12. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice.
Benturquia N; Courtin C; Noble F; Marie-Claire C
Brain Res; 2008 May; 1211():1-5. PubMed ID: 18433738
[TBL] [Abstract][Full Text] [Related]
13. D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja.
Wirtshafter D
Synapse; 1998 Feb; 28(2):154-9. PubMed ID: 9450515
[TBL] [Abstract][Full Text] [Related]
14. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
Isacson R; Kull B; Wahlestedt C; Salmi P
Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway.
Pollack AE; Angerer MR
Brain Res; 2005 Oct; 1058(1-2):189-92. PubMed ID: 16153612
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-fos protein in the experimental epilepsy induced by pilocarpine.
Barone P; Morelli M; Cicarelli G; Cozzolino A; DeJoanna G; Campanella G; DiChiara G
Synapse; 1993 May; 14(1):1-9. PubMed ID: 8511714
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
Zornoza T; Cano-Cebrián MJ; Martínez-García F; Polache A; Granero L
Neuropharmacology; 2005 Dec; 49(7):1067-76. PubMed ID: 16040065
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
